Cargando…
Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers
Variants in SMAD4 or BMPR1A cause juvenile polyposis syndrome, a rare autosomal dominant condition characterized by multiple gastrointestinal hamartomatous polyps. A phenotype of attenuated adenomatous polyposis without hamartomatous polyps is rare. METHODS: We describe a retrospective cohort of ind...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624493/ https://www.ncbi.nlm.nih.gov/pubmed/36049049 http://dx.doi.org/10.14309/ctg.0000000000000527 |
_version_ | 1784822245002051584 |
---|---|
author | Rosner, Guy Petel-Galil, Yael Laish, Ido Levi, Zohar Kariv, Revital Strul, Hana Gilad, Ophir Gluck, Nathan |
author_facet | Rosner, Guy Petel-Galil, Yael Laish, Ido Levi, Zohar Kariv, Revital Strul, Hana Gilad, Ophir Gluck, Nathan |
author_sort | Rosner, Guy |
collection | PubMed |
description | Variants in SMAD4 or BMPR1A cause juvenile polyposis syndrome, a rare autosomal dominant condition characterized by multiple gastrointestinal hamartomatous polyps. A phenotype of attenuated adenomatous polyposis without hamartomatous polyps is rare. METHODS: We describe a retrospective cohort of individuals with SMAD4 or BMPR1A heterozygous germline variants, having ≥10 cumulative colorectal adenomas and/or colorectal cancer without hamartomatous polyps. All individuals had multigene panel and duplication/deletion analysis to exclude other genetic syndromes. RESULTS: The study cohort included 8 individuals. The pathogenic potential of the variants was analyzed. Variants detected included 4 missense variants, 1 nonsense variant, 1 splice site variant, and 2 genomic deletions. Features of pathogenicity were present in most variants, and cosegregation of the variant with polyposis or colorectal cancer was obtained in 7 of the 8 families. Three of 8 individuals had colorectal cancer (age less than 50 years) in addition to the polyposis phenotype. Two individuals had extraintestinal neoplasms (pancreas and ampulla of Vater). DISCUSSION: The clinical phenotype of SMAD4 and BMPR1A variants may infrequently extend beyond the classical juvenile polyposis syndrome phenotype. Applying multigene panel analysis of hereditary cancer-related genes in individuals with unexplained polyposis can provide syndrome-based clinical surveillance for carriers and their family members. |
format | Online Article Text |
id | pubmed-9624493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-96244932022-11-03 Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers Rosner, Guy Petel-Galil, Yael Laish, Ido Levi, Zohar Kariv, Revital Strul, Hana Gilad, Ophir Gluck, Nathan Clin Transl Gastroenterol Article Variants in SMAD4 or BMPR1A cause juvenile polyposis syndrome, a rare autosomal dominant condition characterized by multiple gastrointestinal hamartomatous polyps. A phenotype of attenuated adenomatous polyposis without hamartomatous polyps is rare. METHODS: We describe a retrospective cohort of individuals with SMAD4 or BMPR1A heterozygous germline variants, having ≥10 cumulative colorectal adenomas and/or colorectal cancer without hamartomatous polyps. All individuals had multigene panel and duplication/deletion analysis to exclude other genetic syndromes. RESULTS: The study cohort included 8 individuals. The pathogenic potential of the variants was analyzed. Variants detected included 4 missense variants, 1 nonsense variant, 1 splice site variant, and 2 genomic deletions. Features of pathogenicity were present in most variants, and cosegregation of the variant with polyposis or colorectal cancer was obtained in 7 of the 8 families. Three of 8 individuals had colorectal cancer (age less than 50 years) in addition to the polyposis phenotype. Two individuals had extraintestinal neoplasms (pancreas and ampulla of Vater). DISCUSSION: The clinical phenotype of SMAD4 and BMPR1A variants may infrequently extend beyond the classical juvenile polyposis syndrome phenotype. Applying multigene panel analysis of hereditary cancer-related genes in individuals with unexplained polyposis can provide syndrome-based clinical surveillance for carriers and their family members. Wolters Kluwer 2022-08-31 /pmc/articles/PMC9624493/ /pubmed/36049049 http://dx.doi.org/10.14309/ctg.0000000000000527 Text en © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Rosner, Guy Petel-Galil, Yael Laish, Ido Levi, Zohar Kariv, Revital Strul, Hana Gilad, Ophir Gluck, Nathan Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers |
title | Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers |
title_full | Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers |
title_fullStr | Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers |
title_full_unstemmed | Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers |
title_short | Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers |
title_sort | adenomatous polyposis phenotype in bmpr1a and smad4 variant carriers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624493/ https://www.ncbi.nlm.nih.gov/pubmed/36049049 http://dx.doi.org/10.14309/ctg.0000000000000527 |
work_keys_str_mv | AT rosnerguy adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers AT petelgalilyael adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers AT laishido adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers AT levizohar adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers AT karivrevital adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers AT strulhana adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers AT giladophir adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers AT glucknathan adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers |